| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | androsterone dehydrogenase (B-specific) activity | 6.41e-11 | 4 | 58 | 4 | GO:0047042 | |
| GeneOntologyMolecularFunction | ketoreductase activity | 6.41e-11 | 4 | 58 | 4 | GO:0045703 | |
| GeneOntologyMolecularFunction | chlordecone reductase activity | 6.41e-11 | 4 | 58 | 4 | GO:0047743 | |
| GeneOntologyMolecularFunction | trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity | 3.20e-10 | 5 | 58 | 4 | GO:0047115 | |
| GeneOntologyMolecularFunction | 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity | 3.20e-10 | 5 | 58 | 4 | GO:0047020 | |
| GeneOntologyMolecularFunction | 17-beta-ketosteroid reductase (NADPH) activity | 3.20e-10 | 5 | 58 | 4 | GO:0072555 | |
| GeneOntologyMolecularFunction | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity | 3.20e-10 | 5 | 58 | 4 | GO:0047006 | |
| GeneOntologyMolecularFunction | Delta4-3-oxosteroid 5beta-reductase activity | 3.20e-10 | 5 | 58 | 4 | GO:0047787 | |
| GeneOntologyMolecularFunction | lithocholic acid binding | 3.20e-10 | 5 | 58 | 4 | GO:1902121 | |
| GeneOntologyMolecularFunction | ketosteroid monooxygenase activity | 3.20e-10 | 5 | 58 | 4 | GO:0047086 | |
| GeneOntologyMolecularFunction | geranylgeranyl reductase activity | 9.57e-10 | 6 | 58 | 4 | GO:0045550 | |
| GeneOntologyMolecularFunction | 17-beta-hydroxysteroid dehydrogenase (NADP+) activity | 2.23e-09 | 7 | 58 | 4 | GO:0072582 | |
| GeneOntologyMolecularFunction | 5alpha-androstane-3beta,17beta-diol dehydrogenase activity | 4.45e-09 | 8 | 58 | 4 | GO:0047024 | |
| GeneOntologyMolecularFunction | androsterone dehydrogenase activity | 4.45e-09 | 8 | 58 | 4 | GO:0047023 | |
| GeneOntologyMolecularFunction | enone reductase activity | 4.45e-09 | 8 | 58 | 4 | GO:0035671 | |
| GeneOntologyMolecularFunction | androstan-3-alpha,17-beta-diol dehydrogenase activity | 7.99e-09 | 9 | 58 | 4 | GO:0047044 | |
| GeneOntologyMolecularFunction | NADP+ binding | 7.99e-09 | 9 | 58 | 4 | GO:0070401 | |
| GeneOntologyMolecularFunction | testosterone 17-beta-dehydrogenase (NADP+) activity | 1.33e-08 | 10 | 58 | 4 | GO:0047045 | |
| GeneOntologyMolecularFunction | bile acid binding | 1.33e-08 | 10 | 58 | 4 | GO:0032052 | |
| GeneOntologyMolecularFunction | retinal dehydrogenase activity | 6.28e-08 | 14 | 58 | 4 | GO:0001758 | |
| GeneOntologyMolecularFunction | aldose reductase (NADPH) activity | 6.28e-08 | 14 | 58 | 4 | GO:0004032 | |
| GeneOntologyMolecularFunction | estradiol 17-beta-dehydrogenase [NAD(P)+] activity | 3.00e-07 | 20 | 58 | 4 | GO:0004303 | |
| GeneOntologyMolecularFunction | all-trans-retinol dehydrogenase (NAD+) activity | 6.52e-07 | 24 | 58 | 4 | GO:0004745 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NAD+) activity | 9.13e-07 | 26 | 58 | 4 | GO:0004022 | |
| GeneOntologyMolecularFunction | NADPH binding | 9.13e-07 | 26 | 58 | 4 | GO:0070402 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NADP+) activity | 1.07e-06 | 27 | 58 | 4 | GO:0008106 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase [NAD(P)+] activity | 1.66e-06 | 30 | 58 | 4 | GO:0018455 | |
| GeneOntologyMolecularFunction | aldo-keto reductase (NADPH) activity | 2.17e-06 | 32 | 58 | 4 | GO:0004033 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 2.46e-06 | 33 | 58 | 4 | GO:0033764 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor | 2.78e-06 | 34 | 58 | 4 | GO:0016628 | |
| GeneOntologyMolecularFunction | testosterone dehydrogenase [NAD(P)+] activity | 3.77e-06 | 11 | 58 | 3 | GO:0030283 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity | 4.89e-06 | 39 | 58 | 4 | GO:0016229 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen | 5.42e-06 | 40 | 58 | 4 | GO:0016709 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor | 1.13e-05 | 48 | 58 | 4 | GO:0016620 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors | 2.10e-05 | 56 | 58 | 4 | GO:0016903 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor | 2.77e-05 | 60 | 58 | 4 | GO:0016655 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-CH group of donors | 3.15e-05 | 62 | 58 | 4 | GO:0016627 | |
| GeneOntologyMolecularFunction | NADP binding | 3.15e-05 | 62 | 58 | 4 | GO:0050661 | |
| GeneOntologyMolecularFunction | indanol dehydrogenase activity | 4.96e-05 | 4 | 58 | 2 | GO:0047718 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H | 1.68e-04 | 95 | 58 | 4 | GO:0016651 | |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 2.65e-04 | 107 | 58 | 4 | GO:0033293 | |
| GeneOntologyMolecularFunction | testosterone dehydrogenase (NAD+) activity | 2.95e-04 | 9 | 58 | 2 | GO:0047035 | |
| GeneOntologyMolecularFunction | monooxygenase activity | 3.48e-04 | 115 | 58 | 4 | GO:0004497 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 5.08e-04 | 127 | 58 | 4 | GO:0016616 | |
| GeneOntologyMolecularFunction | steroid binding | 6.04e-04 | 133 | 58 | 4 | GO:0005496 | |
| GeneOntologyMolecularFunction | histone H3K36 methyltransferase activity | 6.34e-04 | 13 | 58 | 2 | GO:0046975 | |
| GeneOntologyMolecularFunction | carboxylic acid binding | 6.44e-04 | 239 | 58 | 5 | GO:0031406 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH-OH group of donors | 6.94e-04 | 138 | 58 | 4 | GO:0016614 | |
| GeneOntologyMolecularFunction | organic acid binding | 8.47e-04 | 254 | 58 | 5 | GO:0043177 | |
| GeneOntologyMolecularFunction | integrin binding | 1.67e-03 | 175 | 58 | 4 | GO:0005178 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 2.17e-03 | 188 | 58 | 4 | GO:0005201 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 2.43e-03 | 194 | 58 | 4 | GO:0016705 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 2.44e-03 | 323 | 58 | 5 | GO:1901681 | |
| GeneOntologyMolecularFunction | Wnt-protein binding | 4.38e-03 | 34 | 58 | 2 | GO:0017147 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 5.17e-03 | 37 | 58 | 2 | GO:0140658 | |
| GeneOntologyMolecularFunction | lipid kinase activity | 6.32e-03 | 41 | 58 | 2 | GO:0001727 | |
| GeneOntologyMolecularFunction | peptidase regulator activity | 6.60e-03 | 257 | 58 | 4 | GO:0061134 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 7.06e-03 | 262 | 58 | 4 | GO:0140097 | |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 7.25e-03 | 44 | 58 | 2 | GO:0140938 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 7.63e-03 | 268 | 58 | 4 | GO:0005539 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 7.86e-03 | 140 | 58 | 3 | GO:0001221 | |
| GeneOntologyMolecularFunction | protein serine/threonine/tyrosine kinase activity | 8.24e-03 | 47 | 58 | 2 | GO:0004712 | |
| GeneOntologyMolecularFunction | nuclear estrogen receptor binding | 1.04e-02 | 53 | 58 | 2 | GO:0030331 | |
| GeneOntologyMolecularFunction | transcription coactivator binding | 1.08e-02 | 54 | 58 | 2 | GO:0001223 | |
| GeneOntologyMolecularFunction | core promoter sequence-specific DNA binding | 1.12e-02 | 55 | 58 | 2 | GO:0001046 | |
| GeneOntologyBiologicalProcess | response to jasmonic acid | 5.63e-11 | 4 | 58 | 4 | GO:0009753 | |
| GeneOntologyBiologicalProcess | progesterone catabolic process | 5.63e-11 | 4 | 58 | 4 | GO:0006709 | |
| GeneOntologyBiologicalProcess | cellular response to jasmonic acid stimulus | 5.63e-11 | 4 | 58 | 4 | GO:0071395 | |
| GeneOntologyBiologicalProcess | C21-steroid hormone catabolic process | 5.63e-11 | 4 | 58 | 4 | GO:0008208 | |
| GeneOntologyBiologicalProcess | farnesol metabolic process | 2.81e-10 | 5 | 58 | 4 | GO:0016487 | |
| GeneOntologyBiologicalProcess | farnesol catabolic process | 2.81e-10 | 5 | 58 | 4 | GO:0016488 | |
| GeneOntologyBiologicalProcess | negative regulation of isoprenoid metabolic process | 2.81e-10 | 5 | 58 | 4 | GO:0045827 | |
| GeneOntologyBiologicalProcess | sesquiterpenoid catabolic process | 2.81e-10 | 5 | 58 | 4 | GO:0016107 | |
| GeneOntologyBiologicalProcess | olefinic compound catabolic process | 2.81e-10 | 5 | 58 | 4 | GO:0120256 | |
| GeneOntologyBiologicalProcess | negative regulation of retinoic acid biosynthetic process | 2.81e-10 | 5 | 58 | 4 | GO:1900053 | |
| GeneOntologyBiologicalProcess | negative regulation of hormone metabolic process | 6.29e-10 | 16 | 58 | 5 | GO:0032351 | |
| GeneOntologyBiologicalProcess | sesquiterpenoid metabolic process | 8.41e-10 | 6 | 58 | 4 | GO:0006714 | |
| GeneOntologyBiologicalProcess | polyprenol catabolic process | 8.41e-10 | 6 | 58 | 4 | GO:0016095 | |
| GeneOntologyBiologicalProcess | response to prostaglandin D | 1.96e-09 | 7 | 58 | 4 | GO:0071798 | |
| GeneOntologyBiologicalProcess | cellular response to prostaglandin D stimulus | 1.96e-09 | 7 | 58 | 4 | GO:0071799 | |
| GeneOntologyBiologicalProcess | regulation of retinoic acid biosynthetic process | 1.96e-09 | 7 | 58 | 4 | GO:1900052 | |
| GeneOntologyBiologicalProcess | parturition | 3.74e-09 | 22 | 58 | 5 | GO:0007567 | |
| GeneOntologyBiologicalProcess | tertiary alcohol metabolic process | 3.74e-09 | 22 | 58 | 5 | GO:1902644 | |
| GeneOntologyBiologicalProcess | daunorubicin metabolic process | 7.02e-09 | 9 | 58 | 4 | GO:0044597 | |
| GeneOntologyBiologicalProcess | regulation of ketone biosynthetic process | 9.27e-09 | 26 | 58 | 5 | GO:0010566 | |
| GeneOntologyBiologicalProcess | doxorubicin metabolic process | 1.17e-08 | 10 | 58 | 4 | GO:0044598 | |
| GeneOntologyBiologicalProcess | regulation of isoprenoid metabolic process | 1.17e-08 | 10 | 58 | 4 | GO:0019747 | |
| GeneOntologyBiologicalProcess | negative regulation of vitamin metabolic process | 1.17e-08 | 10 | 58 | 4 | GO:0046137 | |
| GeneOntologyBiologicalProcess | polyketide metabolic process | 1.17e-08 | 10 | 58 | 4 | GO:0030638 | |
| GeneOntologyBiologicalProcess | aminoglycoside antibiotic metabolic process | 1.17e-08 | 10 | 58 | 4 | GO:0030647 | |
| GeneOntologyBiologicalProcess | regulation of testosterone biosynthetic process | 1.83e-08 | 11 | 58 | 4 | GO:2000224 | |
| GeneOntologyBiologicalProcess | terpenoid catabolic process | 1.83e-08 | 11 | 58 | 4 | GO:0016115 | |
| GeneOntologyBiologicalProcess | olefinic compound biosynthetic process | 4.49e-08 | 35 | 58 | 5 | GO:0120255 | |
| GeneOntologyBiologicalProcess | retinoic acid biosynthetic process | 5.52e-08 | 14 | 58 | 4 | GO:0002138 | |
| GeneOntologyBiologicalProcess | isoprenoid catabolic process | 5.52e-08 | 14 | 58 | 4 | GO:0008300 | |
| GeneOntologyBiologicalProcess | diterpenoid biosynthetic process | 7.51e-08 | 15 | 58 | 4 | GO:0016102 | |
| GeneOntologyBiologicalProcess | testosterone biosynthetic process | 9.99e-08 | 16 | 58 | 4 | GO:0061370 | |
| GeneOntologyBiologicalProcess | C21-steroid hormone metabolic process | 1.65e-07 | 45 | 58 | 5 | GO:0008207 | |
| GeneOntologyBiologicalProcess | regulation of vitamin metabolic process | 1.67e-07 | 18 | 58 | 4 | GO:0030656 | |
| GeneOntologyBiologicalProcess | hormone catabolic process | 3.25e-07 | 21 | 58 | 4 | GO:0042447 | |
| GeneOntologyBiologicalProcess | terpenoid biosynthetic process | 3.25e-07 | 21 | 58 | 4 | GO:0016114 | |
| GeneOntologyBiologicalProcess | regulation of retinoic acid receptor signaling pathway | 3.25e-07 | 21 | 58 | 4 | GO:0048385 | |
| GeneOntologyBiologicalProcess | retinal metabolic process | 3.25e-07 | 21 | 58 | 4 | GO:0042574 | |
| GeneOntologyBiologicalProcess | ketone catabolic process | 3.25e-07 | 21 | 58 | 4 | GO:0042182 | |
| GeneOntologyBiologicalProcess | cellular response to transforming growth factor beta stimulus | 3.83e-07 | 336 | 58 | 9 | GO:0071560 | |
| GeneOntologyBiologicalProcess | glycoside metabolic process | 3.96e-07 | 22 | 58 | 4 | GO:0016137 | |
| GeneOntologyBiologicalProcess | progesterone metabolic process | 3.96e-07 | 22 | 58 | 4 | GO:0042448 | |
| GeneOntologyBiologicalProcess | response to estrogen | 4.39e-07 | 103 | 58 | 6 | GO:0043627 | |
| GeneOntologyBiologicalProcess | response to transforming growth factor beta | 4.55e-07 | 343 | 58 | 9 | GO:0071559 | |
| GeneOntologyBiologicalProcess | cellular response to prostaglandin stimulus | 4.79e-07 | 23 | 58 | 4 | GO:0071379 | |
| GeneOntologyBiologicalProcess | primary alcohol catabolic process | 4.79e-07 | 23 | 58 | 4 | GO:0034310 | |
| GeneOntologyBiologicalProcess | ketone biosynthetic process | 5.52e-07 | 57 | 58 | 5 | GO:0042181 | |
| GeneOntologyBiologicalProcess | regulation of hormone metabolic process | 6.03e-07 | 58 | 58 | 5 | GO:0032350 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA splicing, via spliceosome | 1.10e-06 | 28 | 58 | 4 | GO:0048025 | |
| GeneOntologyBiologicalProcess | secondary metabolic process | 1.25e-06 | 67 | 58 | 5 | GO:0019748 | |
| GeneOntologyBiologicalProcess | polyprenol metabolic process | 1.27e-06 | 29 | 58 | 4 | GO:0016093 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA processing | 1.27e-06 | 29 | 58 | 4 | GO:0050686 | |
| GeneOntologyBiologicalProcess | positive regulation of endothelial cell apoptotic process | 1.91e-06 | 32 | 58 | 4 | GO:2000353 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell apoptotic process | 2.05e-06 | 74 | 58 | 5 | GO:2000351 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA splicing | 2.17e-06 | 33 | 58 | 4 | GO:0033119 | |
| GeneOntologyBiologicalProcess | steroid catabolic process | 2.45e-06 | 34 | 58 | 4 | GO:0006706 | |
| GeneOntologyBiologicalProcess | endothelial cell apoptotic process | 2.83e-06 | 79 | 58 | 5 | GO:0072577 | |
| GeneOntologyBiologicalProcess | response to prostaglandin | 3.10e-06 | 36 | 58 | 4 | GO:0034694 | |
| GeneOntologyBiologicalProcess | isoprenoid biosynthetic process | 3.10e-06 | 36 | 58 | 4 | GO:0008299 | |
| GeneOntologyBiologicalProcess | cellular response to corticosteroid stimulus | 3.21e-06 | 81 | 58 | 5 | GO:0071384 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | MTMR4 SFRP1 SFRP2 CRIM1 AKR1C3 LTBP2 AKR1C4 MAP3K7 AKR1C1 AKR1C2 ZEB2 DNMT1 | 3.45e-06 | 850 | 58 | 12 | GO:0071363 |
| GeneOntologyBiologicalProcess | retinoic acid receptor signaling pathway | 3.87e-06 | 38 | 58 | 4 | GO:0048384 | |
| GeneOntologyBiologicalProcess | retinoic acid metabolic process | 4.77e-06 | 40 | 58 | 4 | GO:0042573 | |
| GeneOntologyBiologicalProcess | response to growth factor | MTMR4 SFRP1 SFRP2 CRIM1 AKR1C3 LTBP2 AKR1C4 MAP3K7 AKR1C1 AKR1C2 ZEB2 DNMT1 | 5.09e-06 | 883 | 58 | 12 | GO:0070848 |
| GeneOntologyBiologicalProcess | negative regulation of lipid biosynthetic process | 5.70e-06 | 91 | 58 | 5 | GO:0051055 | |
| GeneOntologyBiologicalProcess | cellular response to fatty acid | 5.82e-06 | 42 | 58 | 4 | GO:0071398 | |
| GeneOntologyBiologicalProcess | aldehyde metabolic process | 7.04e-06 | 95 | 58 | 5 | GO:0006081 | |
| GeneOntologyBiologicalProcess | alcohol catabolic process | 9.17e-06 | 47 | 58 | 4 | GO:0046164 | |
| GeneOntologyBiologicalProcess | primary alcohol metabolic process | 1.20e-05 | 106 | 58 | 5 | GO:0034308 | |
| GeneOntologyBiologicalProcess | regulation of steroid biosynthetic process | 1.20e-05 | 106 | 58 | 5 | GO:0050810 | |
| GeneOntologyBiologicalProcess | response to xenobiotic stimulus | SFRP1 SFRP2 AKR1C3 AKR1C4 REST AKR1C1 AKR1C2 TNFRSF11B DNMT1 | 1.47e-05 | 525 | 58 | 9 | GO:0009410 |
| GeneOntologyBiologicalProcess | prostaglandin metabolic process | 1.85e-05 | 56 | 58 | 4 | GO:0006693 | |
| GeneOntologyBiologicalProcess | prostanoid metabolic process | 1.99e-05 | 57 | 58 | 4 | GO:0006692 | |
| GeneOntologyBiologicalProcess | regulation of midbrain dopaminergic neuron differentiation | 2.33e-05 | 3 | 58 | 2 | GO:1904956 | |
| GeneOntologyBiologicalProcess | positive regulation of epithelial cell apoptotic process | 2.44e-05 | 60 | 58 | 4 | GO:1904037 | |
| GeneOntologyBiologicalProcess | regulation of mRNA splicing, via spliceosome | 3.11e-05 | 129 | 58 | 5 | GO:0048024 | |
| GeneOntologyBiologicalProcess | cellular response to ketone | 3.23e-05 | 130 | 58 | 5 | GO:1901655 | |
| GeneOntologyBiologicalProcess | cellular response to alcohol | 3.23e-05 | 130 | 58 | 5 | GO:0097306 | |
| GeneOntologyBiologicalProcess | regulation of JUN kinase activity | 3.78e-05 | 67 | 58 | 4 | GO:0043506 | |
| GeneOntologyBiologicalProcess | regulation of steroid metabolic process | 3.87e-05 | 135 | 58 | 5 | GO:0019218 | |
| GeneOntologyBiologicalProcess | response to fatty acid | 4.25e-05 | 69 | 58 | 4 | GO:0070542 | |
| GeneOntologyBiologicalProcess | negative regulation of Wnt signaling pathway, planar cell polarity pathway | 4.65e-05 | 4 | 58 | 2 | GO:0141113 | |
| GeneOntologyBiologicalProcess | Wnt signaling pathway involved in somitogenesis | 4.65e-05 | 4 | 58 | 2 | GO:0090244 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound catabolic process | 5.30e-05 | 73 | 58 | 4 | GO:1901616 | |
| GeneOntologyBiologicalProcess | negative regulation of lipid metabolic process | 5.44e-05 | 145 | 58 | 5 | GO:0045833 | |
| GeneOntologyBiologicalProcess | cellular response to steroid hormone stimulus | 5.56e-05 | 239 | 58 | 6 | GO:0071383 | |
| GeneOntologyBiologicalProcess | negative regulation of small molecule metabolic process | 6.19e-05 | 149 | 58 | 5 | GO:0062014 | |
| GeneOntologyBiologicalProcess | hormone-mediated signaling pathway | 6.24e-05 | 244 | 58 | 6 | GO:0009755 | |
| GeneOntologyBiologicalProcess | regulation of epithelial cell apoptotic process | 6.81e-05 | 152 | 58 | 5 | GO:1904035 | |
| GeneOntologyBiologicalProcess | negative regulation of BMP signaling pathway | 7.59e-05 | 80 | 58 | 4 | GO:0030514 | |
| GeneOntologyBiologicalProcess | regulation of mRNA processing | 8.18e-05 | 158 | 58 | 5 | GO:0050684 | |
| GeneOntologyBiologicalProcess | positive regulation of Wnt signaling pathway | 8.18e-05 | 158 | 58 | 5 | GO:0030177 | |
| GeneOntologyBiologicalProcess | cellular response to calcium ion | 1.10e-04 | 88 | 58 | 4 | GO:0071277 | |
| GeneOntologyBiologicalProcess | positive regulation of reactive oxygen species metabolic process | 1.15e-04 | 89 | 58 | 4 | GO:2000379 | |
| GeneOntologyBiologicalProcess | retinoid metabolic process | 1.15e-04 | 89 | 58 | 4 | GO:0001523 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound biosynthetic process | 1.25e-04 | 277 | 58 | 6 | GO:1901617 | |
| GeneOntologyBiologicalProcess | diterpenoid metabolic process | 1.42e-04 | 94 | 58 | 4 | GO:0016101 | |
| GeneOntologyBiologicalProcess | negative regulation of cell differentiation | SFRP1 SFRP2 CRIM1 SLIT1 REST ZHX2 TERT USH2A TNFRSF11B DNMT1 | 1.47e-04 | 875 | 58 | 10 | GO:0045596 |
| GeneOntologyBiologicalProcess | olefinic compound metabolic process | 1.51e-04 | 180 | 58 | 5 | GO:0120254 | |
| GeneOntologyBiologicalProcess | glycosyl compound metabolic process | 1.54e-04 | 96 | 58 | 4 | GO:1901657 | |
| GeneOntologyCellularComponent | radial spoke stalk | 2.19e-05 | 3 | 57 | 2 | GO:0001536 | |
| GeneOntologyCellularComponent | extracellular matrix | 6.54e-05 | 656 | 57 | 9 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 6.69e-05 | 658 | 57 | 9 | GO:0030312 | |
| GeneOntologyCellularComponent | radial spoke | 7.50e-04 | 15 | 57 | 2 | GO:0001534 | |
| MousePheno | decreased oligodendrocyte number | 1.94e-08 | 25 | 48 | 5 | MP:0009808 | |
| MousePheno | parturition failure | 2.53e-08 | 10 | 48 | 4 | MP:0012010 | |
| MousePheno | hypermyelination | 3.97e-08 | 11 | 48 | 4 | MP:0010050 | |
| MousePheno | abnormal parturition | 8.51e-08 | 33 | 48 | 5 | MP:0002907 | |
| MousePheno | increased oligodendrocyte number | 8.55e-08 | 13 | 48 | 4 | MP:0010160 | |
| MousePheno | long gestation period | 1.62e-07 | 15 | 48 | 4 | MP:0002293 | |
| MousePheno | increased circulating progesterone level | 1.62e-07 | 15 | 48 | 4 | MP:0005186 | |
| MousePheno | long stride length | 1.62e-07 | 15 | 48 | 4 | MP:0010540 | |
| MousePheno | abnormal gestational length | 3.61e-07 | 18 | 48 | 4 | MP:0002292 | |
| MousePheno | dysmyelination | 5.69e-07 | 20 | 48 | 4 | MP:0013438 | |
| MousePheno | abnormal oligodendrocyte morphology | 8.04e-07 | 51 | 48 | 5 | MP:0000953 | |
| MousePheno | prolonged diestrus | 3.14e-06 | 30 | 48 | 4 | MP:0009011 | |
| MousePheno | abnormal diestrus | 5.92e-06 | 35 | 48 | 4 | MP:0009010 | |
| MousePheno | enhanced coordination | 8.29e-06 | 38 | 48 | 4 | MP:0003858 | |
| MousePheno | prolonged estrous cycle | 9.21e-06 | 39 | 48 | 4 | MP:0009006 | |
| MousePheno | decreased vocalization | 1.80e-05 | 46 | 48 | 4 | MP:0020351 | |
| MousePheno | abnormal circulating progesterone level | 2.51e-05 | 50 | 48 | 4 | MP:0005184 | |
| MousePheno | increased stereotypic behavior | 3.17e-05 | 53 | 48 | 4 | MP:0001409 | |
| MousePheno | abnormal progesterone level | 3.41e-05 | 54 | 48 | 4 | MP:0011384 | |
| MousePheno | increased erythrocyte cell number | 6.15e-05 | 123 | 48 | 5 | MP:0003131 | |
| MousePheno | lens dislocation | 1.72e-04 | 6 | 48 | 2 | MP:0031428 | |
| MousePheno | abnormal stride length | 1.76e-04 | 82 | 48 | 4 | MP:0012690 | |
| MousePheno | abnormal myelination | 2.52e-04 | 166 | 48 | 5 | MP:0000920 | |
| MousePheno | increased interleukin level | 3.13e-04 | 174 | 48 | 5 | MP:0014437 | |
| MousePheno | abnormal lens topology | 7.45e-04 | 12 | 48 | 2 | MP:0020486 | |
| MousePheno | abnormal estrous cycle | 7.51e-04 | 120 | 48 | 4 | MP:0001927 | |
| MousePheno | abnormal ovulation cycle | 9.01e-04 | 126 | 48 | 4 | MP:0009344 | |
| MousePheno | increased myeloid cell number | 1.07e-03 | 343 | 48 | 6 | MP:0013663 | |
| MousePheno | decreased miniature inhibitory postsynaptic current amplitude | 1.18e-03 | 15 | 48 | 2 | MP:0014385 | |
| MousePheno | abnormal pregnancy | 1.22e-03 | 235 | 48 | 5 | MP:0009661 | |
| MousePheno | abnormal vocalization | 1.27e-03 | 237 | 48 | 5 | MP:0001529 | |
| Domain | ALDOKETO_REDUCTASE_1 | 1.50e-08 | 10 | 56 | 4 | PS00798 | |
| Domain | Aldo/ket_reductase_CS | 1.50e-08 | 10 | 56 | 4 | IPR018170 | |
| Domain | Aldo/keto_reductase | 1.50e-08 | 10 | 56 | 4 | IPR020471 | |
| Domain | ALDOKETO_REDUCTASE_2 | 1.50e-08 | 10 | 56 | 4 | PS00062 | |
| Domain | ALDOKETO_REDUCTASE_3 | 1.50e-08 | 10 | 56 | 4 | PS00063 | |
| Domain | - | 1.28e-07 | 16 | 56 | 4 | 3.20.20.100 | |
| Domain | NADP_OxRdtase_dom | 1.68e-07 | 17 | 56 | 4 | IPR023210 | |
| Domain | Aldo_ket_red | 1.68e-07 | 17 | 56 | 4 | PF00248 | |
| Domain | Aldo/ket_red/Kv-b | 1.68e-07 | 17 | 56 | 4 | IPR001395 | |
| Domain | CTCK_1 | 2.02e-05 | 18 | 56 | 3 | PS01185 | |
| Domain | VWC_out | 2.39e-05 | 19 | 56 | 3 | SM00215 | |
| Domain | Cys_knot_C | 5.60e-05 | 25 | 56 | 3 | IPR006207 | |
| Domain | CTCK_2 | 5.60e-05 | 25 | 56 | 3 | PS01225 | |
| Domain | AWS | 8.78e-05 | 5 | 56 | 2 | SM00570 | |
| Domain | AWS | 8.78e-05 | 5 | 56 | 2 | PS51215 | |
| Domain | AWS_dom | 8.78e-05 | 5 | 56 | 2 | IPR006560 | |
| Domain | EGF_1 | 1.12e-04 | 255 | 56 | 6 | PS00022 | |
| Domain | BRK | 1.31e-04 | 6 | 56 | 2 | SM00592 | |
| Domain | BRK_domain | 1.31e-04 | 6 | 56 | 2 | IPR006576 | |
| Domain | BRK | 1.31e-04 | 6 | 56 | 2 | PF07533 | |
| Domain | VWFC_1 | 1.70e-04 | 36 | 56 | 3 | PS01208 | |
| Domain | Hirudin/antistatin | 1.84e-04 | 7 | 56 | 2 | IPR011061 | |
| Domain | VWC | 2.00e-04 | 38 | 56 | 3 | SM00214 | |
| Domain | VWFC_2 | 2.00e-04 | 38 | 56 | 3 | PS50184 | |
| Domain | VWF_dom | 2.70e-04 | 42 | 56 | 3 | IPR001007 | |
| Domain | NHL_repeat_subgr | 3.14e-04 | 9 | 56 | 2 | IPR013017 | |
| Domain | IG_FLMN | 3.91e-04 | 10 | 56 | 2 | SM00557 | |
| Domain | NHL | 3.91e-04 | 10 | 56 | 2 | PF01436 | |
| Domain | NHL_repeat | 3.91e-04 | 10 | 56 | 2 | IPR001258 | |
| Domain | Filamin | 4.77e-04 | 11 | 56 | 2 | PF00630 | |
| Domain | FILAMIN_REPEAT | 4.77e-04 | 11 | 56 | 2 | PS50194 | |
| Domain | Filamin/ABP280_rpt | 4.77e-04 | 11 | 56 | 2 | IPR001298 | |
| Domain | Filamin/ABP280_repeat-like | 4.77e-04 | 11 | 56 | 2 | IPR017868 | |
| Domain | TIL | 5.72e-04 | 12 | 56 | 2 | PF01826 | |
| Domain | C8 | 5.72e-04 | 12 | 56 | 2 | PF08742 | |
| Domain | Unchr_dom_Cys-rich | 6.74e-04 | 13 | 56 | 2 | IPR014853 | |
| Domain | C8 | 6.74e-04 | 13 | 56 | 2 | SM00832 | |
| Domain | NHL | 6.74e-04 | 13 | 56 | 2 | PS51125 | |
| Domain | EGF_3 | 6.85e-04 | 235 | 56 | 5 | PS50026 | |
| Domain | EGF_extracell | 7.74e-04 | 60 | 56 | 3 | IPR013111 | |
| Domain | EGF_2 | 7.74e-04 | 60 | 56 | 3 | PF07974 | |
| Domain | TIL_dom | 7.85e-04 | 14 | 56 | 2 | IPR002919 | |
| Domain | Bbox_C | 9.04e-04 | 15 | 56 | 2 | IPR003649 | |
| Domain | BBC | 9.04e-04 | 15 | 56 | 2 | SM00502 | |
| Domain | Post-SET_dom | 1.03e-03 | 16 | 56 | 2 | IPR003616 | |
| Domain | VWD | 1.03e-03 | 16 | 56 | 2 | SM00216 | |
| Domain | PostSET | 1.03e-03 | 16 | 56 | 2 | SM00508 | |
| Domain | VWF_type-D | 1.03e-03 | 16 | 56 | 2 | IPR001846 | |
| Domain | VWFD | 1.03e-03 | 16 | 56 | 2 | PS51233 | |
| Domain | POST_SET | 1.03e-03 | 16 | 56 | 2 | PS50868 | |
| Domain | VWD | 1.03e-03 | 16 | 56 | 2 | PF00094 | |
| Domain | Frizzled/SFRP | 1.03e-03 | 16 | 56 | 2 | IPR015526 | |
| Domain | C345C | 1.17e-03 | 17 | 56 | 2 | SM00643 | |
| Domain | EGF_2 | 1.17e-03 | 265 | 56 | 5 | PS01186 | |
| Domain | Growth_fac_rcpt_ | 1.23e-03 | 156 | 56 | 4 | IPR009030 | |
| Domain | NTR | 1.46e-03 | 19 | 56 | 2 | PF01759 | |
| Domain | Netrin_module_non-TIMP | 1.46e-03 | 19 | 56 | 2 | IPR018933 | |
| Domain | FRI | 1.62e-03 | 20 | 56 | 2 | SM00063 | |
| Domain | PWWP | 1.62e-03 | 20 | 56 | 2 | SM00293 | |
| Domain | LRR_8 | 1.72e-03 | 171 | 56 | 4 | PF13855 | |
| Domain | - | 1.79e-03 | 21 | 56 | 2 | 1.10.2000.10 | |
| Domain | Leu-rich_rpt_typical-subtyp | 1.95e-03 | 177 | 56 | 4 | IPR003591 | |
| Domain | LRR_TYP | 1.95e-03 | 177 | 56 | 4 | SM00369 | |
| Domain | CT | 1.96e-03 | 22 | 56 | 2 | SM00041 | |
| Domain | Quino_amine_DH_bsu | 1.96e-03 | 22 | 56 | 2 | IPR011044 | |
| Domain | PWWP | 2.15e-03 | 23 | 56 | 2 | PF00855 | |
| Domain | PWWP_dom | 2.15e-03 | 23 | 56 | 2 | IPR000313 | |
| Domain | NTR | 2.15e-03 | 23 | 56 | 2 | PS50189 | |
| Domain | Netrin_domain | 2.15e-03 | 23 | 56 | 2 | IPR001134 | |
| Domain | RING | 2.17e-03 | 305 | 56 | 5 | SM00184 | |
| Domain | - | 2.19e-03 | 449 | 56 | 6 | 3.30.40.10 | |
| Domain | PWWP | 2.34e-03 | 24 | 56 | 2 | PS50812 | |
| Domain | Frizzled_dom | 2.34e-03 | 24 | 56 | 2 | IPR020067 | |
| Domain | Chromo_domain | 2.34e-03 | 24 | 56 | 2 | IPR023780 | |
| Domain | FZ | 2.34e-03 | 24 | 56 | 2 | PS50038 | |
| Domain | Fz | 2.34e-03 | 24 | 56 | 2 | PF01392 | |
| Domain | Znf_RING/FYVE/PHD | 2.45e-03 | 459 | 56 | 6 | IPR013083 | |
| Domain | Ephrin_rec_like | 2.53e-03 | 25 | 56 | 2 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 2.53e-03 | 25 | 56 | 2 | IPR011641 | |
| Domain | TIMP-like_OB-fold | 2.74e-03 | 26 | 56 | 2 | IPR008993 | |
| Domain | Chromo | 2.74e-03 | 26 | 56 | 2 | PF00385 | |
| Domain | Znf_RING | 2.90e-03 | 326 | 56 | 5 | IPR001841 | |
| Domain | - | 2.91e-03 | 95 | 56 | 3 | 2.60.120.200 | |
| Domain | DEATH | 2.95e-03 | 27 | 56 | 2 | SM00005 | |
| Pathway | WP_BENZOAPYRENE_METABOLISM | 1.03e-08 | 9 | 44 | 4 | M39344 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_METALS_TO_KEAP1_NRF2_SIGNALIG_PATHWAY | 1.03e-08 | 9 | 44 | 4 | M47817 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_BENZO_A_PYRENRE_TO_CYP_MEDIATED_METABOLISM | 2.68e-08 | 11 | 44 | 4 | M47812 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL | 5.78e-08 | 13 | 44 | 4 | M17842 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL | 5.78e-08 | 13 | 44 | 4 | MM14747 | |
| Pathway | WP_GLUCOCORTICOID_BIOSYNTHESIS | 8.08e-08 | 14 | 44 | 4 | M46449 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL | 8.08e-08 | 14 | 44 | 4 | M27074 | |
| Pathway | WP_MINERALOCORTICOID_BIOSYNTHESIS | 8.08e-08 | 14 | 44 | 4 | M46453 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL | 8.08e-08 | 14 | 44 | 4 | MM14748 | |
| Pathway | REACTOME_SYNTHESIS_OF_PROSTAGLANDINS_PG_AND_THROMBOXANES_TX | 1.10e-07 | 15 | 44 | 4 | MM14870 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL | 7.00e-07 | 23 | 44 | 4 | M1926 | |
| Pathway | REACTOME_PREDNISONE_ADME | 7.00e-07 | 23 | 44 | 4 | MM16639 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL | 7.00e-07 | 23 | 44 | 4 | MM14741 | |
| Pathway | REACTOME_RA_BIOSYNTHESIS_PATHWAY | 1.60e-06 | 28 | 44 | 4 | MM15188 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS | 3.16e-06 | 33 | 44 | 4 | M5967 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS | 3.16e-06 | 33 | 44 | 4 | MM14737 | |
| Pathway | REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM | 1.02e-05 | 44 | 44 | 4 | M499 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 1.12e-05 | 45 | 44 | 4 | MM15344 | |
| Pathway | REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM | 1.12e-05 | 45 | 44 | 4 | MM14751 | |
| Pathway | REACTOME_SIGNALING_BY_RETINOIC_ACID | 1.58e-05 | 49 | 44 | 4 | MM15186 | |
| Pathway | WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4 | 2.24e-05 | 18 | 44 | 3 | M39327 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 2.51e-05 | 55 | 44 | 4 | M14933 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 3.78e-05 | 61 | 44 | 4 | MM14861 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 6.51e-05 | 70 | 44 | 4 | M16794 | |
| Pathway | REACTOME_SIGNALING_BY_WNT | 6.58e-05 | 330 | 44 | 7 | M7847 | |
| Pathway | REACTOME_VISUAL_PHOTOTRANSDUCTION | 1.89e-04 | 92 | 44 | 4 | MM14881 | |
| Pathway | WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER | 2.41e-04 | 98 | 44 | 4 | M39731 | |
| Pathway | WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION | 3.67e-04 | 45 | 44 | 3 | M39355 | |
| Pathway | WP_WNT_SIGNALING_WP428 | 4.15e-04 | 113 | 44 | 4 | M39669 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 4.45e-04 | 48 | 44 | 3 | M27642 | |
| Pathway | REACTOME_DRUG_ADME | 5.05e-04 | 119 | 44 | 4 | MM15692 | |
| Pathway | WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS | 5.14e-04 | 11 | 44 | 2 | M39749 | |
| Pathway | REACTOME_METABOLISM_OF_STEROIDS | 6.26e-04 | 126 | 44 | 4 | MM15553 | |
| Pathway | REACTOME_REGULATION_OF_NPAS4_GENE_EXPRESSION | 7.27e-04 | 13 | 44 | 2 | M46434 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 7.59e-04 | 233 | 44 | 5 | M27099 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_TCF_DEPENDENT_SIGNALING_BY_WNT_LIGAND_ANTAGONISTS | 9.74e-04 | 15 | 44 | 2 | M27273 | |
| Pathway | WP_FERROPTOSIS | 1.03e-03 | 64 | 44 | 3 | M39768 | |
| Pathway | KEGG_WNT_SIGNALING_PATHWAY | 1.23e-03 | 151 | 44 | 4 | M19428 | |
| Pathway | REACTOME_METABOLISM_OF_STEROIDS | 1.32e-03 | 154 | 44 | 4 | M27832 | |
| Pathway | REACTOME_FATTY_ACID_METABOLISM | 1.90e-03 | 170 | 44 | 4 | MM15573 | |
| Pathway | PID_BETA_CATENIN_NUC_PATHWAY | 1.97e-03 | 80 | 44 | 3 | M223 | |
| Pathway | KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_CHONDROITIN_SULFATE | 2.11e-03 | 22 | 44 | 2 | M19166 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II | 2.49e-03 | 183 | 44 | 4 | M39588 | |
| Pathway | WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA | 2.67e-03 | 89 | 44 | 3 | M39563 | |
| Pathway | REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS | 2.80e-03 | 189 | 44 | 4 | MM14772 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | 2.85e-03 | 190 | 44 | 4 | MM15687 | |
| Pathway | REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS | 2.90e-03 | 191 | 44 | 4 | MM15586 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_WNT_INHIBITOR | 3.42e-03 | 28 | 44 | 2 | M47835 | |
| Pathway | REACTOME_VISUAL_PHOTOTRANSDUCTION | 3.72e-03 | 100 | 44 | 3 | M27158 | |
| Pubmed | 7.47e-12 | 4 | 59 | 4 | 20124700 | ||
| Pubmed | Structure and activity of the murine type 5 17beta-hydroxysteroid dehydrogenase gene(1). | 7.47e-12 | 4 | 59 | 4 | 10500239 | |
| Pubmed | Enzymatic properties of a member (AKR1C20) of the aldo-keto reductase family. | 7.47e-12 | 4 | 59 | 4 | 16508162 | |
| Pubmed | 7.47e-12 | 4 | 59 | 4 | 19487289 | ||
| Pubmed | Cloning and chromosomal localization of mouse 20alpha-hydroxysteroid dehydrogenase gene. | 7.47e-12 | 4 | 59 | 4 | 14967952 | |
| Pubmed | 7.47e-12 | 4 | 59 | 4 | 10393440 | ||
| Pubmed | Localization of 20alpha-hydroxysteroid dehydrogenase mRNA in mouse brain by in situ hybridization. | 7.47e-12 | 4 | 59 | 4 | 15193432 | |
| Pubmed | Mouse Akr1cl gene product is a prostaglandin D2 11-ketoreductase with strict substrate specificity. | 7.47e-12 | 4 | 59 | 4 | 31479646 | |
| Pubmed | 7.47e-12 | 4 | 59 | 4 | 15222881 | ||
| Pubmed | 7.47e-12 | 4 | 59 | 4 | 16191478 | ||
| Pubmed | 7.47e-12 | 4 | 59 | 4 | 15577209 | ||
| Pubmed | 7.47e-12 | 4 | 59 | 4 | 10702227 | ||
| Pubmed | 7.47e-12 | 4 | 59 | 4 | 17034817 | ||
| Pubmed | 7.47e-12 | 4 | 59 | 4 | 17629694 | ||
| Pubmed | RECON-Dependent Inflammation in Hepatocytes Enhances Listeria monocytogenes Cell-to-Cell Spread. | 7.47e-12 | 4 | 59 | 4 | 29764944 | |
| Pubmed | 7.47e-12 | 4 | 59 | 4 | 10526179 | ||
| Pubmed | 7.47e-12 | 4 | 59 | 4 | 17888864 | ||
| Pubmed | 7.47e-12 | 4 | 59 | 4 | 17442338 | ||
| Pubmed | 7.47e-12 | 4 | 59 | 4 | 28329705 | ||
| Pubmed | 7.47e-12 | 4 | 59 | 4 | 16018803 | ||
| Pubmed | 7.47e-12 | 4 | 59 | 4 | 17272929 | ||
| Pubmed | 7.47e-12 | 4 | 59 | 4 | 19237748 | ||
| Pubmed | Involvement of 20alpha-hydroxysteroid dehydrogenase in the maintenance of pregnancy in mice. | 7.47e-12 | 4 | 59 | 4 | 18667791 | |
| Pubmed | 7.47e-12 | 4 | 59 | 4 | 28259989 | ||
| Pubmed | 7.47e-12 | 4 | 59 | 4 | 21521174 | ||
| Pubmed | 7.47e-12 | 4 | 59 | 4 | 8274401 | ||
| Pubmed | 7.47e-12 | 4 | 59 | 4 | 16511129 | ||
| Pubmed | 7.47e-12 | 4 | 59 | 4 | 10803568 | ||
| Pubmed | AKR1C1 alleviates LPS‑induced ALI in mice by activating the JAK2/STAT3 signaling pathway. | 7.47e-12 | 4 | 59 | 4 | 34590152 | |
| Pubmed | 7.47e-12 | 4 | 59 | 4 | 7789999 | ||
| Pubmed | Timing of adrenal regression controlled by synergistic interaction between Sf1 SUMOylation and Dax1. | 9.27e-12 | 12 | 59 | 5 | 28893949 | |
| Pubmed | 3.73e-11 | 5 | 59 | 4 | 7737980 | ||
| Pubmed | Retinaldehyde is a substrate for human aldo-keto reductases of the 1C subfamily. | 3.73e-11 | 5 | 59 | 4 | 21851338 | |
| Pubmed | 3.73e-11 | 5 | 59 | 4 | 17872381 | ||
| Pubmed | Mouse 3alpha-hydroxysteroid dehydrogenase mRNA: a marker of lung maturity. | 3.73e-11 | 5 | 59 | 4 | 17064890 | |
| Pubmed | 3.73e-11 | 5 | 59 | 4 | 10672042 | ||
| Pubmed | 3.73e-11 | 5 | 59 | 4 | 38788959 | ||
| Pubmed | Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis. | 3.73e-11 | 5 | 59 | 4 | 16984997 | |
| Pubmed | 3.73e-11 | 5 | 59 | 4 | 18003893 | ||
| Pubmed | The Gαq/11-provoked induction of Akr1c18 in murine luteal cells is mediated by phospholipase C. | 1.12e-10 | 6 | 59 | 4 | 29107092 | |
| Pubmed | 1.12e-10 | 6 | 59 | 4 | 19273550 | ||
| Pubmed | 1.12e-10 | 6 | 59 | 4 | 15860270 | ||
| Pubmed | 1.12e-10 | 6 | 59 | 4 | 15471942 | ||
| Pubmed | MEF2 and NR2F2 cooperate to regulate Akr1c14 gene expression in mouse MA-10 Leydig cells. | 1.12e-10 | 6 | 59 | 4 | 26748576 | |
| Pubmed | 1.12e-10 | 6 | 59 | 4 | 17122075 | ||
| Pubmed | Decidual prolactin silences the expression of genes detrimental to pregnancy. | 1.12e-10 | 6 | 59 | 4 | 17255200 | |
| Pubmed | 2.60e-10 | 7 | 59 | 4 | 26160177 | ||
| Pubmed | Aldo-ketoreductase 1c19 ablation does not affect insulin secretion in murine islets. | 2.60e-10 | 7 | 59 | 4 | 34843575 | |
| Pubmed | 2.60e-10 | 7 | 59 | 4 | 22529366 | ||
| Pubmed | 2.60e-10 | 7 | 59 | 4 | 33127481 | ||
| Pubmed | 2.60e-10 | 7 | 59 | 4 | 12562828 | ||
| Pubmed | 2.60e-10 | 7 | 59 | 4 | 16337335 | ||
| Pubmed | 5.20e-10 | 8 | 59 | 4 | 33584538 | ||
| Pubmed | 5.20e-10 | 8 | 59 | 4 | 20837989 | ||
| Pubmed | 5.20e-10 | 8 | 59 | 4 | 9224647 | ||
| Pubmed | 9.27e-10 | 27 | 59 | 5 | 23471215 | ||
| Pubmed | 9.35e-10 | 9 | 59 | 4 | 33348080 | ||
| Pubmed | The E3 ubiquitin ligase Siah1 regulates adrenal gland organization and aldosterone secretion. | 1.13e-09 | 28 | 59 | 5 | 29212953 | |
| Pubmed | Lack of placental neurosteroid alters cortical development and female somatosensory function. | 1.56e-09 | 10 | 59 | 4 | 36313771 | |
| Pubmed | Endogenous biotin as a marker of adrenocortical cells with steroidogenic potential. | 3.66e-09 | 12 | 59 | 4 | 21256921 | |
| Pubmed | 3.66e-09 | 12 | 59 | 4 | 25774556 | ||
| Pubmed | 4.64e-09 | 3 | 59 | 3 | 19320734 | ||
| Pubmed | Aldo-keto reductases protect metastatic melanoma from ER stress-independent ferroptosis. | 4.64e-09 | 3 | 59 | 3 | 31780644 | |
| Pubmed | 4.64e-09 | 3 | 59 | 3 | 7626489 | ||
| Pubmed | 4.64e-09 | 3 | 59 | 3 | 21232532 | ||
| Pubmed | 4.64e-09 | 3 | 59 | 3 | 13678667 | ||
| Pubmed | 5.28e-09 | 13 | 59 | 4 | 11682476 | ||
| Pubmed | 5.28e-09 | 13 | 59 | 4 | 17062636 | ||
| Pubmed | A link between lung androgen metabolism and the emergence of mature epithelial type II cells. | 5.28e-09 | 13 | 59 | 4 | 15117747 | |
| Pubmed | 5.28e-09 | 13 | 59 | 4 | 24580729 | ||
| Pubmed | 7.38e-09 | 14 | 59 | 4 | 19955443 | ||
| Pubmed | Placental endocrine function shapes cerebellar development and social behavior. | 7.38e-09 | 14 | 59 | 4 | 34400844 | |
| Pubmed | 1.72e-08 | 47 | 59 | 5 | 11208732 | ||
| Pubmed | 1.75e-08 | 17 | 59 | 4 | 32243503 | ||
| Pubmed | Functional dynamics of H3K9 methylation during meiotic prophase progression. | 2.84e-08 | 19 | 59 | 4 | 17599069 | |
| Pubmed | 3.55e-08 | 20 | 59 | 4 | 23636947 | ||
| Pubmed | 3.55e-08 | 20 | 59 | 4 | 24135228 | ||
| Pubmed | 4.63e-08 | 5 | 59 | 3 | 15212687 | ||
| Pubmed | 6.45e-08 | 23 | 59 | 4 | 23685333 | ||
| Pubmed | 9.20e-08 | 25 | 59 | 4 | 26098214 | ||
| Pubmed | Histone H3 lysine 9 methyltransferases, G9a and GLP are essential for cardiac morphogenesis. | 1.09e-07 | 26 | 59 | 4 | 23892084 | |
| Pubmed | 1.27e-07 | 27 | 59 | 4 | 17077188 | ||
| Pubmed | Identification of differentially expressed genes in mouse spermatogenesis. | 1.27e-07 | 27 | 59 | 4 | 14581517 | |
| Pubmed | MRAP deficiency impairs adrenal progenitor cell differentiation and gland zonation. | 1.48e-07 | 28 | 59 | 4 | 29879378 | |
| Pubmed | 1.48e-07 | 28 | 59 | 4 | 21820362 | ||
| Pubmed | 1.62e-07 | 7 | 59 | 3 | 19846565 | ||
| Pubmed | 2.59e-07 | 32 | 59 | 4 | 34288113 | ||
| Pubmed | 4.73e-07 | 37 | 59 | 4 | 21362171 | ||
| Pubmed | 1.00e-06 | 105 | 59 | 5 | 9628581 | ||
| Pubmed | WT1-mediated gene regulation in early urogenital ridge development. | 1.06e-06 | 45 | 59 | 4 | 18391535 | |
| Pubmed | TWIST1 and chromatin regulatory proteins interact to guide neural crest cell differentiation. | 1.21e-06 | 109 | 59 | 5 | 33554859 | |
| Pubmed | 1.90e-06 | 52 | 59 | 4 | 23260145 | ||
| Pubmed | Foxl2 functions in sex determination and histogenesis throughout mouse ovary development. | 2.39e-06 | 55 | 59 | 4 | 19538736 | |
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 8172617 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 8573067 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 7650035 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 19778523 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 11514561 | ||
| Pubmed | 2.83e-06 | 2 | 59 | 2 | 15492289 | ||
| Pubmed | Local androgen inactivation in abdominal visceral adipose tissue. | 2.83e-06 | 2 | 59 | 2 | 14671194 | |
| Interaction | AKR1C4 interactions | 4.29e-09 | 8 | 58 | 4 | int:AKR1C4 | |
| Interaction | AKR1C1 interactions | 2.89e-07 | 20 | 58 | 4 | int:AKR1C1 | |
| Interaction | SFRP1 interactions | 7.47e-07 | 25 | 58 | 4 | int:SFRP1 | |
| Interaction | AKR1C3 interactions | 3.80e-06 | 37 | 58 | 4 | int:AKR1C3 | |
| Interaction | AKR1C2 interactions | 1.89e-05 | 55 | 58 | 4 | int:AKR1C2 | |
| Interaction | ZNF707 interactions | 7.90e-05 | 79 | 58 | 4 | int:ZNF707 | |
| Interaction | SFRP5 interactions | 1.21e-04 | 6 | 58 | 2 | int:SFRP5 | |
| Interaction | TWIST1 interactions | 1.29e-04 | 170 | 58 | 5 | int:TWIST1 | |
| Interaction | UBE2W interactions | 1.68e-04 | 96 | 58 | 4 | int:UBE2W | |
| Cytoband | 10p15-p14 | 4.02e-08 | 6 | 59 | 3 | 10p15-p14 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10p15 | 5.79e-06 | 90 | 59 | 4 | chr10p15 | |
| Cytoband | 13q33.1 | 1.06e-04 | 12 | 59 | 2 | 13q33.1 | |
| Cytoband | 11p15.5 | 4.84e-04 | 118 | 59 | 3 | 11p15.5 | |
| Cytoband | 4q31.3 | 7.37e-04 | 31 | 59 | 2 | 4q31.3 | |
| Cytoband | Xq21.1 | 8.36e-04 | 33 | 59 | 2 | Xq21.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr13q33 | 2.31e-03 | 55 | 59 | 2 | chr13q33 | |
| Cytoband | 7q36.1 | 4.13e-03 | 74 | 59 | 2 | 7q36.1 | |
| GeneFamily | Aldo-keto reductases | 4.08e-08 | 15 | 44 | 4 | 399 | |
| GeneFamily | Secreted frizzled-related proteins | 5.76e-05 | 5 | 44 | 2 | 733 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 5.96e-04 | 15 | 44 | 2 | 529 | |
| GeneFamily | PWWP domain containing | 1.30e-03 | 22 | 44 | 2 | 1147 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 3.09e-03 | 34 | 44 | 2 | 487 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 7.49e-03 | 718 | 44 | 6 | 28 | |
| Coexpression | IRITANI_MAD1_TARGETS_UP | 5.39e-08 | 17 | 59 | 4 | MM826 | |
| Coexpression | LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK | 2.38e-07 | 24 | 59 | 4 | MM766 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN | 2.83e-07 | 25 | 59 | 4 | MM480 | |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS | 6.07e-07 | 30 | 59 | 4 | MM853 | |
| Coexpression | SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3 | 9.64e-07 | 79 | 59 | 5 | MM535 | |
| Coexpression | DESCARTES_ORGANOGENESIS_INTERMEDIATE_MESODERM | 1.29e-06 | 36 | 59 | 4 | MM3660 | |
| Coexpression | NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN | 1.39e-06 | 85 | 59 | 5 | M1451 | |
| Coexpression | WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP | 1.45e-06 | 37 | 59 | 4 | MM630 | |
| Coexpression | VARELA_ZMPSTE24_TARGETS_DN | 3.22e-06 | 45 | 59 | 4 | MM1173 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 5.25e-06 | 196 | 59 | 6 | M3008 | |
| Coexpression | RAO_BOUND_BY_SALL4_ISOFORM_A | 7.79e-06 | 210 | 59 | 6 | MM958 | |
| Coexpression | MARSON_FOXP3_TARGETS_DN | 1.03e-05 | 60 | 59 | 4 | MM847 | |
| Coexpression | NADLER_HYPERGLYCEMIA_AT_OBESITY | 1.50e-05 | 66 | 59 | 4 | MM631 | |
| Coexpression | GOLDRATH_IMMUNE_MEMORY | 1.79e-05 | 69 | 59 | 4 | MM621 | |
| Coexpression | BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP | 2.37e-05 | 74 | 59 | 4 | MM769 | |
| Coexpression | NABA_CORE_MATRISOME | 3.57e-05 | 275 | 59 | 6 | M5884 | |
| Coexpression | GSE3920_IFNA_VS_IFNB_TREATED_ENDOTHELIAL_CELL_DN | 3.64e-05 | 166 | 59 | 5 | M6701 | |
| Coexpression | FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP | 3.88e-05 | 568 | 59 | 8 | M4023 | |
| Coexpression | HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN | 4.09e-05 | 85 | 59 | 4 | MM802 | |
| Coexpression | ZAMORA_NOS2_TARGETS_DN | 4.90e-05 | 89 | 59 | 4 | MM690 | |
| Coexpression | TRAVAGLINI_LUNG_ADVENTITIAL_FIBROBLAST_CELL | 5.37e-05 | 296 | 59 | 6 | M41675 | |
| Coexpression | BAKKER_FOXO3_TARGETS_DN | 6.58e-05 | 188 | 59 | 5 | MM904 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 7.09e-05 | 191 | 59 | 5 | MM17059 | |
| Coexpression | OHM_EMBRYONIC_CARCINOMA_UP | 7.43e-05 | 6 | 59 | 2 | M6244 | |
| Coexpression | FOSTER_KDM1A_TARGETS_UP | 7.85e-05 | 317 | 59 | 6 | MM956 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6 | 8.35e-05 | 102 | 59 | 4 | MM872 | |
| Coexpression | GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN | 8.41e-05 | 198 | 59 | 5 | M8624 | |
| Coexpression | GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_DN | 8.61e-05 | 199 | 59 | 5 | M3583 | |
| Coexpression | NABA_MATRISOME | SFRP1 SFRP2 CRIM1 ADAM15 SLIT1 LTBP2 USH2A SSPOP MUC5AC SVEP1 | 8.88e-05 | 1026 | 59 | 10 | M5889 |
| Coexpression | RICKMAN_HEAD_AND_NECK_CANCER_A | 9.34e-05 | 105 | 59 | 4 | M14228 | |
| Coexpression | DURCHDEWALD_SKIN_CARCINOGENESIS_UP | 1.16e-04 | 111 | 59 | 4 | MM705 | |
| Coexpression | RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP | 1.35e-04 | 219 | 59 | 5 | MM1237 | |
| Coexpression | TABULA_MURIS_SENIS_MESENTERIC_ADIPOSE_TISSUE_MESENCHYMAL_STEM_CELL_OF_ADIPOSE_AGEING | 1.43e-04 | 685 | 59 | 8 | MM3782 | |
| Coexpression | BUSSLINGER_GASTRIC_MATURE_PIT_CELLS | 1.50e-04 | 224 | 59 | 5 | M40013 | |
| Coexpression | SERVITJA_ISLET_HNF1A_TARGETS_DN | 1.62e-04 | 121 | 59 | 4 | MM935 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM | 1.63e-04 | 228 | 59 | 5 | MM1014 | |
| Coexpression | DELYS_THYROID_CANCER_DN | 1.80e-04 | 233 | 59 | 5 | M13273 | |
| Coexpression | TRAVAGLINI_LUNG_MUCOUS_CELL | 1.83e-04 | 125 | 59 | 4 | M41656 | |
| Coexpression | SCHLESINGER_METHYLATED_IN_COLON_CANCER | 2.22e-04 | 10 | 59 | 2 | M821 | |
| Coexpression | BROWN_MYELOID_CELL_DEVELOPMENT_DN | 2.67e-04 | 138 | 59 | 4 | MM1151 | |
| Coexpression | MIKKELSEN_MEF_LCP_WITH_H3K4ME3 | 2.98e-04 | 142 | 59 | 4 | MM840 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_5_6WK_UP | 3.06e-04 | 143 | 59 | 4 | MM989 | |
| Coexpression | NABA_CORE_MATRISOME | 3.55e-04 | 270 | 59 | 5 | MM17057 | |
| Coexpression | GOZGIT_ESR1_TARGETS_DN | 3.62e-04 | 786 | 59 | 8 | M10961 | |
| Coexpression | SERVITJA_LIVER_HNF1A_TARGETS_UP | 3.67e-04 | 150 | 59 | 4 | MM936 | |
| Coexpression | GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_UP | 3.86e-04 | 152 | 59 | 4 | M2938 | |
| Coexpression | NABA_MATRISOME | 3.96e-04 | 1008 | 59 | 9 | MM17056 | |
| Coexpression | INGRAM_SHH_TARGETS_UP | 4.26e-04 | 156 | 59 | 4 | MM550 | |
| Coexpression | GSE4984_GALECTIN1_VS_LPS_STIM_DC_UP | 4.58e-04 | 159 | 59 | 4 | M6502 | |
| Coexpression | BENPORATH_OCT4_TARGETS | 4.92e-04 | 290 | 59 | 5 | M17183 | |
| Coexpression | ENGELMANN_CANCER_PROGENITORS_DN | 5.11e-04 | 69 | 59 | 3 | M9246 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMATURE_PIT_CELLS | 5.26e-04 | 165 | 59 | 4 | M40012 | |
| Coexpression | NFE2L2.V2 | 6.42e-04 | 469 | 59 | 6 | M2870 | |
| Coexpression | MIKKELSEN_MCV6_LCP_WITH_H3K4ME3 | 6.42e-04 | 174 | 59 | 4 | MM836 | |
| Coexpression | GSE3920_IFNA_VS_IFNG_TREATED_FIBROBLAST_UP | 6.56e-04 | 175 | 59 | 4 | M6690 | |
| Coexpression | LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2 | 6.70e-04 | 176 | 59 | 4 | M39223 | |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS | 7.12e-04 | 871 | 59 | 8 | MM1005 | |
| Coexpression | BENPORATH_NOS_TARGETS | 7.14e-04 | 179 | 59 | 4 | M14573 | |
| Coexpression | THUM_MIR21_TARGETS_HEART_DISEASE_UP | 7.45e-04 | 18 | 59 | 2 | MM1241 | |
| Coexpression | THUM_MIR21_TARGETS_HEART_DISEASE_UP | 7.45e-04 | 18 | 59 | 2 | M13796 | |
| Coexpression | LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP | 7.76e-04 | 183 | 59 | 4 | M12621 | |
| Coexpression | WU_CELL_MIGRATION | 7.76e-04 | 183 | 59 | 4 | M2001 | |
| Coexpression | SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN | 8.11e-04 | 324 | 59 | 5 | M2700 | |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | 8.19e-04 | 681 | 59 | 7 | M39175 | |
| Coexpression | SENESE_HDAC3_TARGETS_UP | 8.50e-04 | 495 | 59 | 6 | M8451 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.78e-07 | 187 | 59 | 6 | 76bfe8c42430a230a8bdf299575c444fb7780f24 | |
| ToppCell | IPF-Epithelial-Goblet|IPF / Disease state, Lineage and Cell class | 1.96e-07 | 190 | 59 | 6 | e41dd5a997ad9952810ffecb57737c03ea1d88b3 | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 2.15e-07 | 193 | 59 | 6 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | COVID-19-kidney-Fibroblast-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.28e-07 | 195 | 59 | 6 | 3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2 | |
| ToppCell | proximal-Epithelial-Mucous-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.57e-07 | 199 | 59 | 6 | baac580484124b7c36717b607adcf2cb446e631d | |
| ToppCell | proximal-Epithelial-Mucous|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.57e-07 | 199 | 59 | 6 | 15ba36fa6ad73d0e959e42f18d7acbc14e310dc9 | |
| ToppCell | proximal-3-Epithelial-Mucous|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.57e-07 | 199 | 59 | 6 | 3018378860de084662be0cc46fce421db3bb9ec9 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Mesenchymal-Fibroblasts|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.57e-07 | 199 | 59 | 6 | f19c683f38bca3bfee40396f27423441051dec67 | |
| ToppCell | (5)_Fibroblast-E|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.65e-07 | 200 | 59 | 6 | 75e5ecb05e965e24d569aa2ef5cdf740b1528c06 | |
| ToppCell | Club_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 2.36e-06 | 161 | 59 | 5 | 342f5c61d37df61b35c18f5d258043a8f5cef629 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.99e-06 | 169 | 59 | 5 | 47fd4adfe54777e69a0fabf8bd34f26223f63275 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.99e-06 | 169 | 59 | 5 | e09259d62cd3e42f0919f231ed1164db59b0b6c3 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.36e-06 | 173 | 59 | 5 | 8ac2e9d39c0f76e674f8bd59d1da246bab4867c8 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.55e-06 | 175 | 59 | 5 | af9c5104c86231cfdb93a0f7d7032379efaa009e | |
| ToppCell | 356C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.55e-06 | 175 | 59 | 5 | 4bfae78ac3a2cb9404382aae96d291504a9cfa14 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.30e-06 | 182 | 59 | 5 | 3f1a666fe27dd7529c114539ed5f6b8ca585c875 | |
| ToppCell | Control-Epithelial-Goblet|Epithelial / Disease state, Lineage and Cell class | 4.42e-06 | 183 | 59 | 5 | bdd461349a1ef43a015843937d26e8d3571ecc22 | |
| ToppCell | COPD-Epithelial-Goblet|World / Disease state, Lineage and Cell class | 4.78e-06 | 186 | 59 | 5 | d75fe7640a4b2c450c9759a1b3c3ef2a087f0092 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related-Microfold_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.78e-06 | 186 | 59 | 5 | 6d8dd6d0403d149cb6edb346581fe6c248036785 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.91e-06 | 187 | 59 | 5 | a9316e2818217ec5feae9cf8816f7249803caee6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.91e-06 | 187 | 59 | 5 | 7ea8731288e2a99f45e3958590ee1d76f49ae888 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.04e-06 | 188 | 59 | 5 | 2ee64bc73a2251fd9f374be759b442cf4ed0d19e | |
| ToppCell | COVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type | 5.17e-06 | 189 | 59 | 5 | 84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.30e-06 | 190 | 59 | 5 | 3dcadabbefe0128a5f30ab51234f049ab4d870c6 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations) | 5.30e-06 | 190 | 59 | 5 | 51ca9ef4df3220487152fcf684147730637c7cc1 | |
| ToppCell | IPF-Epithelial-Goblet|World / Disease state, Lineage and Cell class | 5.30e-06 | 190 | 59 | 5 | c29dabf0826663b9d6df51a7af9b76592090e44c | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.44e-06 | 191 | 59 | 5 | f5ce33af56178333730be308253943c54a0724cf | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.44e-06 | 191 | 59 | 5 | 963f4f2e852bbb4faf070aafb0d368297abacd3b | |
| ToppCell | COVID-19-kidney-TAL|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.44e-06 | 191 | 59 | 5 | fe55475ce0666ab5122447a813dc2369e24947b8 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.44e-06 | 191 | 59 | 5 | 9032aa974aa1b7b1095b8d1b58dcb087358a5001 | |
| ToppCell | COVID-19-kidney-Mito-rich_Distal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.44e-06 | 191 | 59 | 5 | 0965f621ebcd92ccdeb21cc27022180ce3cfe910 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.44e-06 | 191 | 59 | 5 | 5717809a1476c20f65bce722c5a57cff92ee0d7a | |
| ToppCell | NS-critical-d_16-33-Epithelial-Secretory-diff|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.58e-06 | 192 | 59 | 5 | 02b11233b4da2d85b96498b3c6e22e3a31b3d049 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.58e-06 | 192 | 59 | 5 | 5d24bb6c6c17a6b803b241d065b31896a7d86c37 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.58e-06 | 192 | 59 | 5 | 562df5e87038c500dd3a003fe5374cb31946b145 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.58e-06 | 192 | 59 | 5 | c6795ceba90f1a5d441dff92a737b9c7d28b06b0 | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-G_(Club-Clara_cells)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.58e-06 | 192 | 59 | 5 | c7c232545fad8ad327ab94bd0def8dc5daacd03d | |
| ToppCell | 343B-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.72e-06 | 193 | 59 | 5 | 8ede7038a222c7e7ecaf7e86520823cf606cbee7 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.72e-06 | 193 | 59 | 5 | 0e7d7adfaa7191e34038fcda6677561ae13934eb | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.87e-06 | 194 | 59 | 5 | e0228f593c3493175962a4817500d4337ddc4e88 | |
| ToppCell | IPF-Stromal-Fibroblast|Stromal / Disease state, Lineage and Cell class | 5.87e-06 | 194 | 59 | 5 | da3e1d39575969a069ef43e552afe94b2f441d0b | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 6.01e-06 | 195 | 59 | 5 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | Epithelial_cells-Club_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 6.01e-06 | 195 | 59 | 5 | b758676abfc4e6930b696d270ecc0ea461b87a54 | |
| ToppCell | facs-Skin-nan-18m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.01e-06 | 195 | 59 | 5 | ba7cb80deb872c9184769f0dd57855c3c6a432bf | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.01e-06 | 195 | 59 | 5 | e7230a849ea31e6eef9bc6f5468938499450582d | |
| ToppCell | PCW_05-06-Mesenchymal|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.17e-06 | 196 | 59 | 5 | dca52c57ba35d9395cdbca8b881f12ece721b10f | |
| ToppCell | Nasal_Brush-Epithelial-Goblet_1|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 6.17e-06 | 196 | 59 | 5 | e16f0831f1f677b28e4a8014f0aede7e713d4f04 | |
| ToppCell | COPD-Stromal-Fibroblast|Stromal / Disease state, Lineage and Cell class | 6.17e-06 | 196 | 59 | 5 | 4930eeb303d174c28fd91021723e26fdf1af9170 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.17e-06 | 196 | 59 | 5 | e02301642243df483fd066d978317c113c04692b | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-secretory_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.32e-06 | 197 | 59 | 5 | d6c9da7a3a6d2bcb13e2fc6605c8a59e7fb121c5 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.32e-06 | 197 | 59 | 5 | 80b05c8ad9c1edc5dea3236079372475431343fe | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.32e-06 | 197 | 59 | 5 | 4ea3f57cd88b8a6bb7cb4b9e3545c0fa8f331886 | |
| ToppCell | BL-critical-LOC-Epithelial-Secretory_LYPD2|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.48e-06 | 198 | 59 | 5 | 484d16aaa601a1e11b871b0475dd01a2de1a29ce | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-D|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.48e-06 | 198 | 59 | 5 | fd14efd8e6c74a04bde985c08dc34217c0ef1bab | |
| ToppCell | distal-mesenchymal-Adventitial_Fibroblast-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.48e-06 | 198 | 59 | 5 | bfd720e2dae3b6b3dc2bf8b2096c554fd456e756 | |
| ToppCell | moderate-Epithelial-Secretory|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.48e-06 | 198 | 59 | 5 | 7d96d7105a849c7280ce87bd76ce130ac47384fd | |
| ToppCell | NS-critical-LOC-Epithelial-Secretory_LYPD2|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.48e-06 | 198 | 59 | 5 | 4a481e1edb80b950c823ed926842cd5132cfb27f | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Secretory-diff|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.48e-06 | 198 | 59 | 5 | 361f3062f73a0add16dd6fbe927698416515879f | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.48e-06 | 198 | 59 | 5 | d0ecace1fad24ce50b0935036fabb07e6c9e372d | |
| ToppCell | 367C-Fibroblasts-Fibroblast-E-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 6.64e-06 | 199 | 59 | 5 | 2aed8f4a225a3762a5e7ce99aacad9b2a37d61f1 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Perivascular_fibroblast|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.64e-06 | 199 | 59 | 5 | dfc5c7a4a093baa7158dd8d4d29a870d9c469a3f | |
| ToppCell | 368C-Fibroblasts-Fibroblast-D-|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.64e-06 | 199 | 59 | 5 | 5a425e7d11c5911ff5855c27a7f058a7ed7abbb0 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-E|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 6.64e-06 | 199 | 59 | 5 | c40ca26345753a2197bd9389d7323f7491c1e11d | |
| ToppCell | 368C-Fibroblasts-Fibroblast-D|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.64e-06 | 199 | 59 | 5 | 66545eb7f65e450b742628fd431956e13330a0d3 | |
| ToppCell | distal-2-mesenchymal-Adventitial_Fibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.64e-06 | 199 | 59 | 5 | 97b475f9110ef7bb29d9cf2109b7e43177830f05 | |
| ToppCell | distal-Epithelial-Mucous-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.64e-06 | 199 | 59 | 5 | 0af89ef40807fc4ad79ab82a2186ab6e866c6931 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Perivascular_fibroblast-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.64e-06 | 199 | 59 | 5 | c1760581c34b81d1d92c67500a1c8944e9cc6dad | |
| ToppCell | (5)_Fibroblast-D|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.64e-06 | 199 | 59 | 5 | 3f415620ad8b8d8c6871e1353e13f87b281fcc0e | |
| ToppCell | moderate-Epithelial-Secretory-diff|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.80e-06 | 200 | 59 | 5 | 6f29ef9dcf126c5c19386f6aa9a20c38a2c8ccc8 | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_1-CARM1P1--L3-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.80e-06 | 200 | 59 | 5 | 47791c93d03ee17c1ce17e27f075be4fc6f2590e | |
| ToppCell | moderate-Epithelial|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.80e-06 | 200 | 59 | 5 | 095783c9b75113ae350c2d5fb1195d71b41fa695 | |
| ToppCell | NS-moderate-d_07-13-Epithelial|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.80e-06 | 200 | 59 | 5 | 85940b4bf7971b872469dea8b8d7a45bdeb2a909 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-E-|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.80e-06 | 200 | 59 | 5 | 57b9d6aa2265ab178a5886f36ecc66115bd382a8 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_adventitial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.80e-06 | 200 | 59 | 5 | fc3c4778841c4b8bac0afb458352614b2c460617 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Mesenchymal-Fibroblasts|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 6.80e-06 | 200 | 59 | 5 | bfa73bc5f8a6c7de8353ca049a921ef19f7f4437 | |
| ToppCell | Biopsy_Other_PF-Mesenchymal-PLIN2+_Fibroblasts|Biopsy_Other_PF / Sample group, Lineage and Cell type | 6.80e-06 | 200 | 59 | 5 | 0aa316b71f195ecf17ee897e307f8928a755a637 | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_1-CARM1P1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.80e-06 | 200 | 59 | 5 | f75d95376a340d467c4392b872b2a2dbdd184556 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 6.80e-06 | 200 | 59 | 5 | 0a86656d48e4238d0e4d592d477d29f7ba7c2ec0 | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Club|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 6.80e-06 | 200 | 59 | 5 | 85f946dd3831acf3488c87efba96689cc2667c3a | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_1-CARM1P1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.80e-06 | 200 | 59 | 5 | fae26560ba3b0b638b6bcf92f05330824b31d21b | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.80e-06 | 200 | 59 | 5 | 3fa7d9ea67f9cc55478d085da53babd03dbe9bb1 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_adventitial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.80e-06 | 200 | 59 | 5 | 6b48ddde83bc6c941d557844aa214d4d2c8e736d | |
| ToppCell | Fibroblast|World / shred by cell class for parenchyma | 6.80e-06 | 200 | 59 | 5 | dec9ce1bc2571197003596f32e5f742ede72aa79 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.80e-06 | 200 | 59 | 5 | 1e75d1302c22e1b1666c19c0c9259d5cc8be16d5 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Club-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.80e-06 | 200 | 59 | 5 | 8a44a4f7ea9358f2194a490e79601c98ff7fdcb0 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-E|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.80e-06 | 200 | 59 | 5 | ddfbc004e7bd2fd3f11f046ed8fc049277160547 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Club|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.80e-06 | 200 | 59 | 5 | 30d428510c68da96c7c8cfd472f449ebb9631132 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.58e-05 | 140 | 59 | 4 | 5e81fa3a19d23f0e9cae3878431ca1f78dff7238 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.99e-05 | 144 | 59 | 4 | 1c001a5a3bbe4ecbce8305f8b260e933033550dd | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.10e-05 | 145 | 59 | 4 | 051d964ff6bdc12ba3f0459d3e6ab16fa9507b0b | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.10e-05 | 145 | 59 | 4 | 07acbf086cffce0628accf078d31bf190f803988 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Mucinous_Lepidic_Adenocarcinoma-7|TCGA-Lung / Sample_Type by Project: Shred V9 | 4.81e-05 | 151 | 59 | 4 | 3dfa1d89975ffaa45b26833538244153d50c60a7 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Mucinous_Lepidic_Adenocarcinoma|TCGA-Lung / Sample_Type by Project: Shred V9 | 4.81e-05 | 151 | 59 | 4 | 60bb6de5d9b13402bc18cb6d5e51078326dff8e2 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-D-|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.19e-05 | 154 | 59 | 4 | dd3d34f065820e706515a13619f19a5b12734c8e | |
| ToppCell | 367C-Fibroblasts-Fibroblast-D|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.19e-05 | 154 | 59 | 4 | 4bfda1c41efbb86d829b3797d1168bf2587c3c97 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.02e-05 | 160 | 59 | 4 | 8bcdbcfdf1e0ace6053e8de82762f6e2f86bba7a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.02e-05 | 160 | 59 | 4 | 2d391ba6f7adb55dfa89feecc10cc9ce97e5fe74 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.63e-05 | 164 | 59 | 4 | c5bfae7e9497185548c243d6f9ebadbcef48ba7f | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.63e-05 | 164 | 59 | 4 | 76b0ac220b7ca22fbea28a507f01f96ae9f53932 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.63e-05 | 164 | 59 | 4 | 911081739174ec68bc0893c804e4276b206bea7d | |
| Computational | DRG (dorsal root ganglia) genes. | 8.23e-04 | 384 | 32 | 6 | MODULE_2 | |
| Computational | CNS genes. | 9.30e-04 | 546 | 32 | 7 | MODULE_137 | |
| Computational | Trachea genes. | 1.23e-03 | 415 | 32 | 6 | MODULE_6 | |
| Computational | Genes in the cancer module 311. | 1.28e-03 | 18 | 32 | 2 | MODULE_311 | |
| Computational | Intermediate filaments. | 1.40e-03 | 75 | 32 | 3 | MODULE_154 | |
| Computational | Genes in the cancer module 186. | 1.58e-03 | 20 | 32 | 2 | MODULE_186 | |
| Computational | Intermediate filaments and keratins. | 1.69e-03 | 80 | 32 | 3 | MODULE_357 | |
| Computational | Genes in the cancer module 297. | 1.69e-03 | 80 | 32 | 3 | MODULE_297 | |
| Computational | Genes in the cancer module 71. | 1.91e-03 | 22 | 32 | 2 | MODULE_71 | |
| Drug | Pregnanes | 3.79e-11 | 4 | 58 | 4 | ctd:D011278 | |
| Drug | tetralol | 3.79e-11 | 4 | 58 | 4 | ctd:C019106 | |
| Drug | 3',3'',5',5''-tetrabromophenolphthalein | 3.79e-11 | 4 | 58 | 4 | ctd:C018156 | |
| Drug | cloxazolam | 3.79e-11 | 4 | 58 | 4 | ctd:C005522 | |
| Drug | Hydroxysteroids | 1.89e-10 | 5 | 58 | 4 | ctd:D006914 | |
| Drug | cresolphthalein | 1.89e-10 | 5 | 58 | 4 | ctd:C010092 | |
| Drug | Medazepam | 5.66e-10 | 6 | 58 | 4 | ctd:D008472 | |
| Drug | Nitrazepam | 2.63e-09 | 8 | 58 | 4 | ctd:D009567 | |
| Drug | 4-hydroxybenzoic acid | 4.73e-09 | 9 | 58 | 4 | ctd:C038193 | |
| Drug | 20-alpha-Dihydroprogesterone | 4.73e-09 | 9 | 58 | 4 | ctd:D004092 | |
| Drug | octyl gallate | 7.87e-09 | 10 | 58 | 4 | ctd:C016627 | |
| Drug | Dihydroxydihydrobenzopyrenes | 1.23e-08 | 11 | 58 | 4 | ctd:D004101 | |
| Drug | chlordecone alcohol | 1.23e-08 | 11 | 58 | 4 | CID000013946 | |
| Drug | cyclopentanone | 1.57e-08 | 3 | 58 | 3 | ctd:C007201 | |
| Drug | 5-dihydrodeoxycorticosterone | 1.57e-08 | 3 | 58 | 3 | ctd:C454687 | |
| Drug | 4-benzoylbenzoic acid | 1.57e-08 | 3 | 58 | 3 | ctd:C058818 | |
| Drug | cyclopentanol | 1.57e-08 | 3 | 58 | 3 | ctd:C016327 | |
| Drug | dichloro(4-cymene)ruthenium(II) | 1.57e-08 | 3 | 58 | 3 | ctd:C530610 | |
| Drug | Phenolphthalein | 1.85e-08 | 12 | 58 | 4 | ctd:D020113 | |
| Drug | DMBA-3,4-dihydrodiol | 2.66e-08 | 13 | 58 | 4 | CID000050096 | |
| Drug | flunisolide | 2.66e-08 | 13 | 58 | 4 | ctd:C007734 | |
| Drug | 1-acenaphthenol | 3.72e-08 | 14 | 58 | 4 | CID000022750 | |
| Drug | 5-alpha-Dihydroprogesterone | 3.72e-08 | 14 | 58 | 4 | ctd:D043582 | |
| Drug | Meclofenamic Acid | 3.72e-08 | 14 | 58 | 4 | ctd:D008469 | |
| Drug | tetrahydrodeoxycorticosterone | 6.26e-08 | 4 | 58 | 3 | ctd:C009413 | |
| Drug | gliquidone | 6.26e-08 | 4 | 58 | 3 | ctd:C010969 | |
| Drug | DBD-H | 6.26e-08 | 4 | 58 | 3 | CID000131382 | |
| Drug | oxcarbazepine | 1.43e-07 | 19 | 58 | 4 | ctd:C036006 | |
| Drug | NSC86000 | 1.56e-07 | 5 | 58 | 3 | CID000257630 | |
| Drug | benzo(a)pyrene-7,8-dione | 1.78e-07 | 20 | 58 | 4 | ctd:C076588 | |
| Drug | Chrysenes | 1.78e-07 | 20 | 58 | 4 | ctd:D002911 | |
| Drug | Flunitrazepam | 2.20e-07 | 21 | 58 | 4 | ctd:D005445 | |
| Drug | benzene dihydrodiol | 2.68e-07 | 22 | 58 | 4 | CID000000418 | |
| Drug | AC1L93E5 | 3.12e-07 | 6 | 58 | 3 | CID000412383 | |
| Drug | acenaphthene-1-ol | 3.12e-07 | 6 | 58 | 3 | ctd:C023723 | |
| Drug | Estazolam | 3.12e-07 | 6 | 58 | 3 | ctd:D004949 | |
| Drug | 3-hydroxyhexobarbital | 3.12e-07 | 6 | 58 | 3 | CID000439898 | |
| Drug | Glipizide | 3.12e-07 | 6 | 58 | 3 | ctd:D005913 | |
| Drug | phenolphthalein | 3.72e-07 | 58 | 58 | 5 | CID000004764 | |
| Drug | Glycyrrhetinic Acid | 3.88e-07 | 24 | 58 | 4 | ctd:D006034 | |
| Drug | Pregnanolone | 4.61e-07 | 25 | 58 | 4 | ctd:D011280 | |
| Drug | 9,10-phenanthrenequinone | 4.61e-07 | 25 | 58 | 4 | ctd:C005399 | |
| Drug | 4-hydroxyequilenin-o-quinone | 5.45e-07 | 7 | 58 | 3 | ctd:C117714 | |
| Drug | zomepirac | 5.45e-07 | 7 | 58 | 3 | ctd:C020549 | |
| Drug | 2-cyclohexen-1-ol | 8.71e-07 | 8 | 58 | 3 | CID000013198 | |
| Drug | benzo(a)pyrene 7,8-dihydrodiol | 1.13e-06 | 31 | 58 | 4 | ctd:C017228 | |
| Drug | 20 alpha-dihydroprogesterone | 3.24e-06 | 40 | 58 | 4 | CID000008956 | |
| Drug | fenamic acid | 3.40e-06 | 12 | 58 | 3 | ctd:C001209 | |
| Drug | o-quinone | 3.58e-06 | 41 | 58 | 4 | CID000011421 | |
| Drug | androsterone glucuronide | 4.34e-06 | 43 | 58 | 4 | CID000114833 | |
| Drug | 4-formyl-benzoate | 4.41e-06 | 13 | 58 | 3 | CID000012088 | |
| Drug | Flufenamic Acid | 5.22e-06 | 45 | 58 | 4 | ctd:D005439 | |
| Drug | naphthalene-1,2-dihydrodiol | 5.22e-06 | 45 | 58 | 4 | CID000000362 | |
| Drug | Dydrogesterone | 5.60e-06 | 14 | 58 | 3 | ctd:D004394 | |
| Drug | 6-.beta.-Naltrexol | 5.60e-06 | 14 | 58 | 3 | CID000631219 | |
| Drug | 3-hydroxyandrostan-17-one | 6.20e-06 | 102 | 58 | 5 | CID000000225 | |
| Drug | alpha-methylcinnamic acid | 6.38e-06 | 2 | 58 | 2 | ctd:C510582 | |
| Drug | (10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE | 6.38e-06 | 2 | 58 | 2 | DB07768 | |
| Drug | baccharin | 6.38e-06 | 2 | 58 | 2 | ctd:C012764 | |
| Drug | drospirenone | 6.98e-06 | 15 | 58 | 3 | ctd:C035144 | |
| Drug | 9-cis-retinal | 8.58e-06 | 16 | 58 | 3 | ctd:C031390 | |
| Drug | androstane-3,17-dione | 8.66e-06 | 51 | 58 | 4 | CID000000443 | |
| Drug | benzo(a)pyrene-1,6-quinone | 1.04e-05 | 17 | 58 | 3 | ctd:C030233 | |
| Drug | Timolol maleate salt [26921-17-5]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 1.05e-05 | 196 | 58 | 6 | 5280_DN | |
| Drug | Debrisoquin sulfate [581-88-4]; Up 200; 9uM; MCF7; HT_HG-U133A | 1.15e-05 | 199 | 58 | 6 | 3207_UP | |
| Drug | Hexestrol | 1.17e-05 | 55 | 58 | 4 | ctd:D006589 | |
| Drug | cloxazolam | 1.25e-05 | 18 | 58 | 3 | CID000002816 | |
| Drug | benzo(a)pyrene-3,6-quinone | 1.25e-05 | 18 | 58 | 3 | ctd:C018003 | |
| Drug | Ruthenium Compounds | 1.25e-05 | 18 | 58 | 3 | ctd:D017975 | |
| Drug | 1,2-dihydroxynaphthalene | 1.35e-05 | 57 | 58 | 4 | CID000011318 | |
| Drug | NSC36919 | 1.45e-05 | 58 | 58 | 4 | CID000235496 | |
| Drug | AC1L8ZBW | 1.48e-05 | 19 | 58 | 3 | CID000435356 | |
| Drug | Irganox 1010 | 1.91e-05 | 3 | 58 | 2 | CID000064819 | |
| Drug | coniferaldehyde | 2.02e-05 | 21 | 58 | 3 | ctd:C075384 | |
| Drug | Dutasteride | 2.02e-05 | 21 | 58 | 3 | ctd:D000068538 | |
| Drug | chlordecone | 2.58e-05 | 67 | 58 | 4 | CID000000299 | |
| Drug | 2'-Monophosphoadenosine 5'-Diphosphoribose | 2.68e-05 | 23 | 58 | 3 | DB03461 | |
| Drug | medazepam | 3.06e-05 | 24 | 58 | 3 | CID000004041 | |
| Drug | 5 beta-pregnane-3,20-dione | 3.43e-05 | 72 | 58 | 4 | CID000092745 | |
| Drug | Diazepam | 3.82e-05 | 74 | 58 | 4 | ctd:D003975 | |
| Drug | glycolithocholic acid | 3.91e-05 | 26 | 58 | 3 | CID000115245 | |
| Drug | Budesonide | 5.19e-05 | 80 | 58 | 4 | ctd:D019819 | |
| Drug | 1,10-phenanthroline | 5.72e-05 | 82 | 58 | 4 | ctd:C025205 | |
| Drug | farnesal | 6.35e-05 | 5 | 58 | 2 | ctd:C084519 | |
| Drug | Hydrocortisone | 6.69e-05 | 167 | 58 | 5 | ctd:D006854 | |
| Drug | estazolam | 9.69e-05 | 35 | 58 | 3 | CID000003261 | |
| Drug | quercitrin | 1.06e-04 | 36 | 58 | 3 | CID005280459 | |
| Drug | trifluoperazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A | 1.14e-04 | 187 | 58 | 5 | 6984_UP | |
| Drug | 1 C2 | 1.24e-04 | 100 | 58 | 4 | CID005327152 | |
| Drug | Mefenamic Acid | 1.34e-04 | 39 | 58 | 3 | ctd:D008528 | |
| Drug | Salicylic Acid | 1.34e-04 | 39 | 58 | 3 | ctd:D020156 | |
| Drug | Nadolol [42200-33-9]; Up 200; 13uM; MCF7; HT_HG-U133A | 1.36e-04 | 194 | 58 | 5 | 4139_UP | |
| Drug | NSC3260 | 1.39e-04 | 195 | 58 | 5 | CID000220461 | |
| Drug | Betahistine mesylate [54856-23-4]; Up 200; 17.2uM; MCF7; HT_HG-U133A | 1.39e-04 | 195 | 58 | 5 | 2833_UP | |
| Drug | Amiprilose hydrochloride [60414-06-4]; Up 200; 11.8uM; PC3; HT_HG-U133A | 1.42e-04 | 196 | 58 | 5 | 4000_UP | |
| Drug | Sulfadoxine [2447-57-6]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 1.42e-04 | 196 | 58 | 5 | 7205_UP | |
| Drug | Isopropamide iodide [71-81-8]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 1.42e-04 | 196 | 58 | 5 | 3461_UP | |
| Drug | Adiphenine hydrochloride [50-42-0]; Up 200; 11.4uM; HL60; HT_HG-U133A | 1.42e-04 | 196 | 58 | 5 | 1872_UP | |
| Drug | Epirizole [18694-40-1]; Up 200; 17uM; HL60; HT_HG-U133A | 1.46e-04 | 197 | 58 | 5 | 1845_UP | |
| Drug | Ioversol [87771-40-2]; Down 200; 5uM; HL60; HT_HG-U133A | 1.46e-04 | 197 | 58 | 5 | 3026_DN | |
| Disease | Neoplasms, Hormone-Dependent | 7.21e-09 | 3 | 58 | 3 | C0027661 | |
| Disease | Ambiguous Genitalia | 7.19e-08 | 5 | 58 | 3 | C0266362 | |
| Disease | Pseudohermaphroditism | 7.19e-08 | 5 | 58 | 3 | C0033804 | |
| Disease | Hermaphroditism | 7.19e-08 | 5 | 58 | 3 | C0019269 | |
| Disease | Intersex Conditions | 7.19e-08 | 5 | 58 | 3 | C2930618 | |
| Disease | Sex Differentiation Disorders | 7.19e-08 | 5 | 58 | 3 | C2930619 | |
| Disease | Disorders of Sex Development | 2.51e-07 | 7 | 58 | 3 | C0036875 | |
| Disease | MALE PSEUDOHERMAPHRODITISM: DEFICIENCY OF TESTICULAR 17,20-DESMOLASE | 3.80e-06 | 2 | 58 | 2 | C1839840 | |
| Disease | 46,XY SEX REVERSAL 8 | 3.80e-06 | 2 | 58 | 2 | 614279 | |
| Disease | 46,XY disorder of sex development due to testicular 17,20-desmolase deficiency | 3.80e-06 | 2 | 58 | 2 | cv:C1839840 | |
| Disease | 46,XY sex reversal 8 (is_implicated_in) | 3.80e-06 | 2 | 58 | 2 | DOID:0111773 (is_implicated_in) | |
| Disease | Sotos syndrome 1 (implicated_via_orthology) | 1.14e-05 | 3 | 58 | 2 | DOID:0112103 (implicated_via_orthology) | |
| Disease | autosomal recessive limb-girdle muscular dystrophy (implicated_via_orthology) | 1.14e-05 | 3 | 58 | 2 | DOID:0110274 (implicated_via_orthology) | |
| Disease | autosomal recessive limb-girdle muscular dystrophy type 2H (implicated_via_orthology) | 1.14e-05 | 3 | 58 | 2 | DOID:0110282 (implicated_via_orthology) | |
| Disease | Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 measurement | 2.27e-05 | 4 | 58 | 2 | EFO_0803113 | |
| Disease | Degenerative polyarthritis | 3.44e-05 | 93 | 58 | 4 | C0029408 | |
| Disease | Osteoarthrosis Deformans | 3.44e-05 | 93 | 58 | 4 | C0086743 | |
| Disease | Hydrophthalmos | 3.78e-05 | 5 | 58 | 2 | C0020302 | |
| Disease | cortolone glucuronide (1) measurement | 5.67e-05 | 6 | 58 | 2 | EFO_0800552 | |
| Disease | eye morphology measurement | 7.01e-05 | 218 | 58 | 5 | EFO_0007858 | |
| Disease | CHARGE syndrome (implicated_via_orthology) | 7.92e-05 | 7 | 58 | 2 | DOID:0050834 (implicated_via_orthology) | |
| Disease | diastolic blood pressure, self reported educational attainment | 1.06e-04 | 8 | 58 | 2 | EFO_0004784, EFO_0006336 | |
| Disease | FEV/FEC ratio | 1.27e-04 | 1228 | 58 | 10 | EFO_0004713 | |
| Disease | alkaline phosphatase measurement | 1.52e-04 | 1015 | 58 | 9 | EFO_0004533 | |
| Disease | Neoplastic Cell Transformation | 1.64e-04 | 139 | 58 | 4 | C0007621 | |
| Disease | pulmonary fibrosis | 2.06e-04 | 11 | 58 | 2 | EFO_0009448 | |
| Disease | microphthalmia (implicated_via_orthology) | 2.47e-04 | 12 | 58 | 2 | DOID:10629 (implicated_via_orthology) | |
| Disease | Endometrioma | 2.88e-04 | 161 | 58 | 4 | C0269102 | |
| Disease | Endometriosis | 2.88e-04 | 161 | 58 | 4 | C0014175 | |
| Disease | response to methotrexate | 4.48e-04 | 16 | 58 | 2 | GO_0031427 | |
| Disease | hypertrophic cardiomyopathy (is_marker_for) | 5.07e-04 | 17 | 58 | 2 | DOID:11984 (is_marker_for) | |
| Disease | syndrome (implicated_via_orthology) | 5.69e-04 | 18 | 58 | 2 | DOID:225 (implicated_via_orthology) | |
| Disease | Mammary Carcinoma, Human | 5.70e-04 | 525 | 58 | 6 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 5.70e-04 | 525 | 58 | 6 | C1257931 | |
| Disease | Mammary Neoplasms | 5.82e-04 | 527 | 58 | 6 | C1458155 | |
| Disease | acute myeloid leukemia (is_implicated_in) | 6.13e-04 | 84 | 58 | 3 | DOID:9119 (is_implicated_in) | |
| Disease | Breast Carcinoma | 6.48e-04 | 538 | 58 | 6 | C0678222 | |
| Disease | body weight | 7.45e-04 | 1261 | 58 | 9 | EFO_0004338 | |
| Disease | muscular dystrophy (implicated_via_orthology) | 7.78e-04 | 21 | 58 | 2 | DOID:9884 (implicated_via_orthology) | |
| Disease | Inhalant adrenergic use measurement | 9.04e-04 | 96 | 58 | 3 | EFO_0009941 | |
| Disease | cortical surface area measurement | 1.17e-03 | 1345 | 58 | 9 | EFO_0010736 | |
| Disease | chronic myeloid leukemia (is_marker_for) | 1.29e-03 | 27 | 58 | 2 | DOID:8552 (is_marker_for) | |
| Disease | intelligence, response to cranial radiation therapy | 1.39e-03 | 28 | 58 | 2 | EFO_0004337, EFO_0010950 | |
| Disease | pulse pressure measurement | 1.49e-03 | 1392 | 58 | 9 | EFO_0005763 | |
| Disease | Drugs used in diabetes use measurement | 1.60e-03 | 255 | 58 | 4 | EFO_0009924 | |
| Disease | body surface area | 1.62e-03 | 643 | 58 | 6 | EFO_0022196 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GLKYKPVCNQVECHP | 181 | P17516 | |
| LYALVQLGQPCDCLP | 21 | O94766 | |
| HLILCTGQQYQVPCP | 766 | Q8NHU2 | |
| LRKCCNHPYLINGAE | 1091 | Q9HCK8 | |
| SKTHPPKCIQCGQYL | 346 | P26358 | |
| PKCIQCGQYLDDPDL | 351 | P26358 | |
| GLKYKPVCNQVECHP | 181 | P42330 | |
| LHQRLCQLKGPTCQY | 721 | Q13444 | |
| LQLKYPHLPCLQVGQ | 316 | Q9UL18 | |
| KNGLYLHNNPLPCDC | 211 | Q86WK7 | |
| IHCDLKPENILLCNP | 236 | Q9Y463 | |
| LNVAEQLCCYPGPVL | 301 | Q9H3Z7 | |
| KDAICAISCHPYQPL | 606 | Q8TBY9 | |
| PGCPKVYHADCLNLT | 2136 | Q96L73 | |
| VNTCHLPLNPALCIK | 871 | O75747 | |
| NGPKPLNCPHCDYKT | 356 | Q13127 | |
| HNLCGQKPTIRDPYC | 241 | Q7Z353 | |
| HPNIVKLYGACLNPV | 86 | O43318 | |
| GLICLNKNQLPPICY | 2021 | P98088 | |
| KDLYHPICPLGQCKV | 291 | Q86XP1 | |
| GCCHLKLPIPDQQLY | 1146 | Q9NYA4 | |
| LLIYLLPPCNCDTLH | 506 | O43182 | |
| LRKCCNHPYLINGAE | 741 | Q8TD26 | |
| HLDTKPYACQIPGCT | 466 | Q8NEA6 | |
| IHLCCVNPKYLPILT | 61 | Q30KP9 | |
| AHLIKSCPGECYQLI | 481 | Q9NSG2 | |
| PIICDKYCPLGLLKN | 541 | Q9NZV1 | |
| LECPQGYKRLNLTHC | 606 | Q14767 | |
| ISCPQKYPCLLQHLM | 3406 | Q8NDH2 | |
| DLYPGGCQQLLHLCV | 41 | Q9HB75 | |
| SLDKLYALCGQHCPI | 1906 | P56715 | |
| GLHCDRCLPLYNDKP | 546 | O75445 | |
| VCCNGVLYNPKPGHR | 3191 | O75445 | |
| KEPVYQLPCGHLLCR | 496 | O94941 | |
| KPIPANLQLCHGIEY | 41 | Q96HF1 | |
| GCSILPLPYMIQCKH | 426 | Q6NUJ1 | |
| LPRSQCPCQLHGQLY | 2941 | A2VEC9 | |
| NIPGCYRQILKHPCN | 636 | Q9H0K6 | |
| LSYLCPKECPHIVFQ | 211 | Q96H78 | |
| LVLYLKNGADCPCHQ | 246 | Q8N474 | |
| NHLIPYCKAVSCGKP | 1836 | Q4LDE5 | |
| GLKYKPVCNQVECHP | 181 | Q04828 | |
| GLKYKPVCNQVECHP | 181 | P52895 | |
| RCLPHFYIIGQPKCG | 251 | Q7LFX5 | |
| KPFLCYCDPDVGHLI | 126 | Q6ZU45 | |
| SHQLLCDKCPPGTYL | 36 | O00300 | |
| YFPCGNITKCLPQLL | 31 | Q9HBX9 | |
| GLICISYPLHHPKQQ | 126 | Q5JUR7 | |
| CPKAYHLLCLNLTQP | 1341 | Q9BZ95 | |
| HPNVILNPLYVCAEC | 101 | Q9Y6X8 | |
| LQHQLLHTGEKPYPC | 361 | Q96CS4 | |
| NNAEICLLPLDYGPC | 31 | P48307 | |
| PLHLLRYVCLFCGKN | 206 | Q70CQ2 | |
| CLERYKNPKVLPCLH | 26 | Q9C040 | |
| LRIHSGEKPYECPNC | 301 | O60315 | |
| DGQPLTVYPCHICTK | 376 | Q9Y462 | |
| PCRKLYCLHGICQPN | 1341 | O75093 | |
| LRLHSGEKPYQCPEC | 601 | Q6IV72 | |
| AQCPYGVLLKTHCPL | 401 | O14746 | |
| QHYPELCACLDKQRP | 166 | P19075 | |
| LDRYQCPKVLPCLHT | 26 | O75382 | |
| DPCLLPEVCLLYNKG | 161 | Q96H79 |